Sort by
Refine Your Search
-
theoretical and/or computational research in Nonequilibrium Statistical Physics and Active Matter, under the supervision of Ramin Golestanian. For more information concerning our current areas of research
-
will engage in theoretical and/or computational research in Nonequilibrium Statistical Physics and Active Matter, under the supervision of Ramin Golestanian. For more information concerning our current
-
Description For our location in Hamburg we are seeking: PhD Student in Molecular and Structural Microbiology – Microbiome Science Remuneration Group 13 | Limited: 3 years | Starting date: earliest possible | ID: FSDO020/2025 | Deadline: 15.01.2026 | Full-time/Part-time DESY, with more than...
-
serves to support a doctoral programme. The position is temporary for the duration of the doctoral process, but initially up to 3 years. An extension for the completion of the doctorate is possible within
-
to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from our strong basic research program, our long-term goal is to develop innovative therapeutic approaches to better
-
individually, for example through training opportunities and the structured JuDocS program for doctoral candidates: https://www.fz-juelich.de/en/judocs . Health and well-being: Your health is important to us
-
(Wissenschaftszeitvertragsgesetz) from 01.01.2026. TU Ilmenau offers three PhD positions within the DFG Priority Program SPP 2477 “Nitrides4Future – Novel Materials and Device Concepts”. The here offered position is one of two
-
Contract Act (Wissenschaftszeitvertragsgesetz) from 01.01.2026. TU Ilmenau offers three PhD positions within the DFG Priority Program SPP 2477 “Nitrides4Future – Novel Materials and Device Concepts
-
and developing dependable automated driving systems based on software and systems engineering approaches. The Institute for Software and Systems Engineering (ISSE) is one of the two computer
-
to combine ribonucleic acid (RNA) research with infection biology. Based on novel findings from our strong basic research program, our long-term goal is to develop innovative therapeutic approaches to better